Cargando...

Unexpected side effect in mCRC: A care-compliant case report of regorafenib-induced hyperammonemic encephalopathy

RATIONALE: Regorafenib represents a treatment option in heavily pretreated patients affected by metastatic colorectal cancer (mCRC). Its safety profile is typical of small-molecule tyrosine-kinase inhibitors (TKIs) and most adverse events are manageable. PATIENT CONCERNS: A 56 years-old Caucasian ma...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Medicine (Baltimore)
Autores principales: Quirino, Michela, Rossi, Sabrina, Schinzari, Giovanni, Basso, Michele, Strippoli, Antonia, Cassano, Alessandra, Barone, Carlo
Formato: Artigo
Lenguaje:Inglês
Publicado: Wolters Kluwer Health 2017
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5406055/
https://ncbi.nlm.nih.gov/pubmed/28422839
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000006522
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!